{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:22:01Z","timestamp":1750537321989},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 76-year-old man with prostate cancer pT2c N0 M0 R1 GS9 (4+5) operated 2009 and radiated postoperatively underwent restaging by <jats:sup>68<\/jats:sup>Ga-PSMA-PET in January 2017 because of PSA rise at 0.44 ng\/ml under medication with GnRH analogues. An intense focal uptake of the diffusely enlarged left adrenal gland was observed as the only pathological finding. Further evaluation by MRI imaging revealed a plump left adrenal gland with a relatively enlarged diameter of 2 cm and excluded tumor and nodular hyperplasia as well. Without any change of the therapeutic regime the patient presented in July 2017 with a PSA level of 0.05 ng\/ml and no sign of cancer progress.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001881","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T09:01:05Z","timestamp":1509008465000},"page":"50-51","source":"Crossref","is-referenced-by-count":14,"title":["Uptake of 68Ga\u2013Prostate-Specific Membrane Antigen PET in Adrenal Gland"],"prefix":"10.1097","volume":"43","author":[{"given":"Pia","family":"Strele-Trieb","sequence":"first","affiliation":[{"name":"From the *Institute of Nuclear Medicine, General Hospital Wels, Wels; Institutes of \u2020Nuclear Medicine and \u2021Radiology, Kepler University Hospital, Neuromed Campus, Linz; \u00a7Department of Urology and \u2225Institute of Nuclear Medicine, Gespag Hospital Steyr, Steyr; and \u00b6Department of Radiology, Clinic of Nuclear Medicine, Medical University Graz, Graz, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Dunzinger","sequence":"additional","affiliation":[{"name":"From the *Institute of Nuclear Medicine, General Hospital Wels, Wels; Institutes of \u2020Nuclear Medicine and \u2021Radiology, Kepler University Hospital, Neuromed Campus, Linz; \u00a7Department of Urology and \u2225Institute of Nuclear Medicine, Gespag Hospital Steyr, Steyr; and \u00b6Department of Radiology, Clinic of Nuclear Medicine, Medical University Graz, Graz, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sonnberger","sequence":"additional","affiliation":[{"name":"From the *Institute of Nuclear Medicine, General Hospital Wels, Wels; Institutes of \u2020Nuclear Medicine and \u2021Radiology, Kepler University Hospital, Neuromed Campus, Linz; \u00a7Department of Urology and \u2225Institute of Nuclear Medicine, Gespag Hospital Steyr, Steyr; and \u00b6Department of Radiology, Clinic of Nuclear Medicine, Medical University Graz, Graz, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Wolfsgruber","sequence":"additional","affiliation":[{"name":"From the *Institute of Nuclear Medicine, General Hospital Wels, Wels; Institutes of \u2020Nuclear Medicine and \u2021Radiology, Kepler University Hospital, Neuromed Campus, Linz; \u00a7Department of Urology and \u2225Institute of Nuclear Medicine, Gespag Hospital Steyr, Steyr; and \u00b6Department of Radiology, Clinic of Nuclear Medicine, Medical University Graz, Graz, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pichler","sequence":"additional","affiliation":[{"name":"From the *Institute of Nuclear Medicine, General Hospital Wels, Wels; Institutes of \u2020Nuclear Medicine and \u2021Radiology, Kepler University Hospital, Neuromed Campus, Linz; \u00a7Department of Urology and \u2225Institute of Nuclear Medicine, Gespag Hospital Steyr, Steyr; and \u00b6Department of Radiology, Clinic of Nuclear Medicine, Medical University Graz, Graz, Austria."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/RLU.0000000000001518","article-title":"68Ga-PSMA-HBED uptake on cervicothoracic (stellate) ganglia, a common pitfall on PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","article-title":"[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/RLU.0000000000001731","article-title":"Extraosseous extension of aggressive vertebral hemangioma as a potential pitfall on 68Ga-PSMA PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/RLU.0000000000001296","article-title":"Paget disease: a potential pitfall in PSMA PET for prostate cancer","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/RLU.0000000000001543","article-title":"PSMA uptake in mediastinal sarcoidosis","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/RLU.0000000000001222","article-title":"Healing sacral fracture masquerading as metastatic bone disease on a 68Ga-PSMA PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1097\/RLU.0000000000001310","article-title":"68Ga-PSMA PET\/MR showing intense PSMA uptake in nodular fasciitis mimicking prostate cancer metastasis","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib8-20230925","first-page":"65","article-title":"A potential pitfall in the use of 68Ga-PSMA PET\/CT: anthracosis","volume":"36","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/RLU.0000000000001148","article-title":"PSMA expression in papillary thyroid carcinoma: opening a new horizon in management of thyroid cancer?","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/RLU.0000000000001777","article-title":"68Ga-PSMA uptake in neurofibromas demonstrated on PET\/CT in a patient with neurofibromatosis type 1","volume":"42","year":"2017","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201801000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:03:40Z","timestamp":1695618220000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201801000-00016"}},"subtitle":["A Potential Pitfall"],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001881","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}